Bowling for Pfizer: Who’s Behind the BioNTech Vaccine?

From Development to Approval At the end of November, it was revealed that the Oxford Vaccine Group had conducted the clinical trial showing its vaccine for COVID-19 had an efficacy of 90 per cent exclusively on volunteers aged 55 and below, thereby excluding precisely the demographic most at risk from the disease. Shares in its … Continue reading Bowling for Pfizer: Who’s Behind the BioNTech Vaccine?